ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts

November 23, 1974

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999